The effects of RANTES/CCR5 promoter polymorphisms on HIV disease progression in HIV-infected Koreans

International Journal of Immunogenetics

Volumn 35, Issue 2, 2008, Pages 101-105

  Jang, D H ^a   Choi, B S ^a   Kim, S S ^a  

^a Korea National Institute of Health   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; RANTES;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE COURSE; GENE FREQUENCY; GENE SEQUENCE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KOREA; MAJOR CLINICAL STUDY; MUTATION; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; VIRUS INFECTION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ASIAN CONTINENTAL ANCESTRY GROUP; CHEMOKINE CCL5; FEMALE; GENE FREQUENCY; HIV-1; HUMANS; KOREA; MALE; POINT MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CCR5;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 40449100781     PISSN: 17443121     EISSN: 1744313X     Source Type: Journal    
DOI: 10.1111/j.1744-313X.2007.00743.x     Document Type: Article

References (28)

1. Alkhatib, G., Combadiere, C., Broder, C.C., Feng, Y., Kennedy, P.E., Murphy, P.M. et al 1996) CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science, 272, 1955.
2. Berger, E.A., Murphy, P.M. Farber, J.M. (1999) Chemokine receptors as HIV- 1 coreceptors: roles in viral entry, tropism, and disease. Annual Review of Immunology, 17, 657.
3. Berson, J.F., Long, D., Doranz, B.J., Rucker, J., Jirik, F.R. Doms, R.W. (1996) A seven-transmembrane domain receptor involved in fusion and entry of T- cell-tropic human immunodeficiency virus type 1 strains. Journal of Virology, 70, 6288.
4. Brumme, Z.L., Chan, K.J., Dong, W., Hogg, R., O'Shaughnessy, M.V., Montaner, J.S. et al 2002) CCR5Delta32 and promoter polymorphisms are not correlated with initial virological or immunological treatment response. AIDS, 15 (17 2259.
5. Choi, B.S., Cha, S.H., Kim, S.S., Park, Y.K. Lee, J.S. (2002) High frequencies of the CCR2b-64I and SDF-13′A mutations with HIV infection in Koreans. Immune Network, 2 (2 86.
6. Clegg, A.O., Ashton, L.J., Biti, R.A., Badhwar, P., Williamson, P., Kaldor, J.M. et al 2000) Links CCR5 promoter polymorphisms, CCR5 59029A and CCR5 59353C, are under represented in HIV-1-infected long-term non-progressors. The Australian Long-Term Non-Progressor Study Group. AIDS, 14 (2 103.
7. Cocchi, F., DeVico, A.L., Garzino-Demo, A., Arya, S.K., Gallo, R.C. Lusso, P. (1995) Identification of RANTES, MIP-1a, and MIP-1b as the major HIV-suppressive factors produced by CD81 T cells. Science, 270, 1811.
8. D'Sousa, M.P. Harden, V.A. (1996) Chemokines and HIV-1 second receptors. Nature Medicine, 2, 1293.
9. Dean, M., Carrington, M., Winkler, C., Huttley, G.A., Smith, M.W., Allikmets, R. et al 1996) Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science, 273, 1856.
10. Easterbrook, P.J., Rostron, T., Ives, N., Troop, M., Gazzard, B.G. Rowland-Jones, S.L. (1999) Chemokine receptor polymorphisms and human immunodeficiency virus disease progression. Journal of Infection and Disease, 180 (4 1096.
11. Gallo, R.C., Garzino-Demo, A. DeVico, A.L. (1999) HIV infection and pathogenesis: what about chemokines? Journal of Clinical Immunology, 19, 293.
12. Kostrikis, L.G., Huang, Y., Moore, J.P., Wolinsky, S.M., Zhang, L., Guo, Y. et al 1998) A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation. Nature Medicine, 4 (3 350.
13. Liu, H., Chao, D., Nakayama, E.E., Taguchi, H., Goto, M., Xin, X. et al 1999) Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proceedings of the National Academy of Sciences USA, 96, 4581.
14. Mack, M., Luckow, B., Nelson, P.J., Cihak, J., Simmons, G., Clapham, P.R. et al 1998) Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: a novel inhibitory mechanism of HIV infectivity. Journal of Experimental Medicine, 187, 1215.
15. Magierowska, M., Theodorou, I., Debré, P., Sanson, F., Autran, B., Rivière, Y. et al 1999) Combined genotypes of CCR5, CCR2, SDF1, and HLA genes can predict the long-term nonprogressor status in human immunodeficiency virus-1-infected individuals. Blood, 93 (3 936.
16. McDermott, D.H., Zimmerman, P.A., Guignard, F., Kleeberger, C.A., Leitman, S.F. Murphy, P.M. (1998) CCR5 promoter polymorphism and HIV-1 disease progression. Multicenter AIDS Cohort Study (MACS). Lancet, 352, 866.
17. Morgan, D., Mahe, C., Mayanja, B. Whitworth, J.A. (2002) Progression to symptomatic disease in people infected with HIV-1 in rural Uganda: prospective cohort study. British Medical Journal, 324, 193.
18. Mummidi, S., Ahuja, S.S., Gonzalez, E., Anderson, S.A., Santiago, E.N., Stephan, K.T. et al 1998) Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression. Nature Medicine, 4, 786.
19. Munoz, A., Kirby, A.J., He, Y.D., Margolick, J.B., Visscher, B.R., Rinaldo, C.R. et al 1995) Long-term survivors with HIV-1 infection: incubation period and longitudinal patterns of CD4 lymphocytes. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 8, 496.
20. Paxton, W.A., Neumann, A.U., Kang, S., Deutch, L., Brown, R.C., Koup, R.A. et al 2001) RANTES production from CD4+ lymphocytes correlates with host genotype and rates of human immunodeficiency virus type 1 disease progression. Journal of Infection and Disease, 183, 1678.
21. Polo, S., Veglia, F., Malnati, M.S., Gobbi, C., Farci, P., Raiteri, R. et al 1999) Longitudinal analysis of serum chemokine levels in the course of HIV-1 infection. AIDS, 13, 447.
22. Saha, K., Bentsman, G., Chess, L. Volsky, D.J. (1997) Endogenous production of beta-chemokines by CD4+, but not CD8+, T-cell clones correlates with the clinical state of human immunodeficiency virus type 1 (HIV-1) -infected individuals and may be responsible for blocking infection with non-syncytium-inducing HIV-1 in vitro. Journal of Virology, 72, 876.
23. Sharif, F., Ollier, W.E. Hajeer, A.H. (1999) A rare polymorphism at position in the human RANTES promoter. European Journal of Immunogenetics, 26 (5 373.
24. Stewart, G. (1998) Chemokine genes - beating the odds. Nature Medicine, 4, 275.
25. Than, S., Tumaliuan, J.A., Tamma, S., Morales, M., Bakshi, S. Pahwa, S. (1999) Chemokine pattern in relation to disease state in human immunodeficiency virus-infected children. AIDS Research Human Retroviruses, 15 (14 1279.
26. Zanussi, S., D'Andrea, M., Simonelli, C., Tirelli, U. De Paoli, P. (1996) Serum levels of RANTES and MIP-1 alpha in HIV-positive long-term survivors and progressor patients. AIDS, 10, 1431.
27. Zhao, X.Y., Lee, S.S., Wong, K.H., Chan, K.C., Ma, S., Yam, W.C. et al 2004) Effects of single nucleotide polymorphisms in the RANTES promoter region in healthy and HIV-infected indigenous Chinese. European Journal of Immunogenetics, 31 (4 179.
28. Zhu, T., Mo, H., Wang, N., Nam, D.S., Cao, Y., Koup, R.A. et al 1993) Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science, 61, 1179.